당뇨병성 신증 연구의 최신지견

키워드

참고문헌 (28)

1. Breyer MD, "Mouse models of diabetic nephropathy", J Am Soc Nephrol, 16, pp.27~45 (2005)
2. Wang A, "Interference with TGF-β signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria", Am J Physiol Renal Physiol, 293, pp.1657~1665 (2007)
3. Wu F, "Conditional targeting in the kidney", Nephron Physiol, 107, pp.10~16 (2007)
4. Utomo AR, "Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice", Nat Biotechnol, 17, pp.1091~1096 (1999)
5. "Wang J.Cre/lox Mouse Breeding.Science Creative Q"[URL]
6. Lee GS, "Mesangial cell culture: its role in the understanding of the pathogenesis of glomerular disease", Ann Acad Med Singapore, 24, pp.851~855 (1995)
7. Jefferson JA, "Proteinuria in diabetic kidney disease: a mechanistic viewpoint", Kidney Int, 74, pp.22~36 (2008)
8. 이은영, "당뇨병성 신증에서 사구체 족세포(podocyte)의 손상 기전", 당뇨병, 27(4), pp.343~351 (2003), 대한당뇨병학회
9. 이은영, "신사구체 고혈압에 의한 신손상기전: 족세포 신장 (stretch)에 의한 혈관내피성장인자의 조절", 대한고혈압학회지, 12, pp.25~32 (2006)
10. 이은영, "당뇨병성 신증에서 angiopoietins 유전자의 변화", The Korean Journal of Nephrology, 26(3), pp.311~319 (2007), 대한신장학회
11. Satchell SC, "What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?", Diabetologia, 51, pp.714~725 (2008)
12. Nitta K, "Glomerular endothelial cell culture and its application", Nippon Rinsho, 52, pp.1389~1395 (1994)
13. Savage CO, "The biology of the glomerulus: endothelial cells", Kidney Int, 45, pp.314~319 (1994)
14. Lee EY, "Antioxidants ameliorate the expression of vascular endothelial growth factor mediated by protein kinase C in diabetic podocytes", Nephrol Dial Transplant, 21, pp.1496~1503 (2006)
15. Kreisberg JI, "Renal cell culture", J Electron Microsc Tech, 9, pp.235~263 (1988)
16. Flyvbjerg A, "Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody", Diabetes, 51, pp.3090~3094 (2002)
17. 이은영, "Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes", Experimental and Molecular Medicine, 36(1), pp.65~70 (2004), 생화학분자생물학회
18. de Vriese AS, "Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes", J Am Soc Nephrol, 12, pp.993~1000 (2001)
19. 고장현, "당뇨병성 신증에서 퍼록시솜 증식 활성화 수용체 감마 촉진제, 안지오텐신Ⅱ 수용체 억제제 및 알파-리포산이 신장 혈관 내피세포 성장인자의 발현에 미치는 영향", 당뇨병, 28(5), pp.367~376 (2004), 대한당뇨병학회
20. 이미영, "Beneficial Effects of Thiazolidinediones on Diabetic Nephropathy in OLETF Rats", Yonsei Medical Journal, 48(2), pp.301~307 (2007), 연세대학교의과대학
21. Gröne HJ, "Expression of vascular endothelial growth factor in renal vascular disease and renal allografts", J Pathol, 177, pp.259~267 (1995)
22. Shulman K, "Expression of vascular permeability factor (VPF", VEGF) is altered in many glomerular diseases, 1996, pp.7, 661~666
23. Chow, FY, "Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice", Kidney Int, 69, pp.73~80 (2006)
24. Gu L, "Pravastatin inhibits carboxymethyllysine-induced monocyte chemoattractant protein 1 expression in podocytes via prevention of signaling events", Nephron Exp Nephrol, 106, pp.1~10 (2007)
25. Lee EY, "Podocyte-derived MCP-1 is stimulatedby TGF-β and might contribute to diabetic nephropathy", J Am Soc Nephrol, 18, pp.655~656 (2007)
26. Fornoni A, "Role of inflammation in diabetic nephropathy", Curr Diabetes Rev, 4, pp.10~17 (2008)
27. Navarro-González JF, "The role of inflammatory cytokines in diabetic nephropathy", J Am Soc Nephrol, 19, pp.433~442 (2008)
28. 이은영, "Blockade of Oxidative Stress by Vitamin C Ameliorates Albuminuria and Renal Sclerosis in Experimental Diabetic Rats", Yonsei Medical Journal, 48(5), pp.847~855 (2007), 연세대학교의과대학

관련 논문AI추천